30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Instil Bio Inc (TIL)

The most recent insider trading activity occurred on September 10, 2025, with Sandeep Laumas, CFO and CBO, selling shares valued at approximately $1.4 million. Prior to this, significant buying activity was observed on March 23, 2021, involving multiple executives and entities.
Stock chart
Ticker: TIL Exchange: NSM


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Laumas Sandeep
CFO and CBO
2 sales — total 701,667 USD
Sale 10 Sep 2025
Value US$2,463,911.70 | Price 162.14 | Shares 73,489
Sale 10 Sep 2025
Value US$4,779,555.40 | Price 436.62 | Shares 95,618
Proposed sale 10 Sep 2025
Value US$253,704.05 | Price 16.69 | Shares 13,001
Buy 23 Mar 2021
Value US$9,000,000.00 | Price 20.00 | Shares 450,000
Buy 23 Mar 2021
Value US$392,400.00 | Price 20.00 | Shares 19,620
Buy 23 Mar 2021
Value US$967,800.00 | Price 20.00 | Shares 48,390
Buy 23 Mar 2021
Value US$2,337,600.00 | Price 20.00 | Shares 116,880
Buy 23 Mar 2021
Value US$209,400.00 | Price 20.00 | Shares 10,470
Buy 23 Mar 2021
Value US$2,092,800.00 | Price 20.00 | Shares 104,640
Buy 23 Mar 2021
Value US$9,000,000.00 | Price 20.00 | Shares 450,000
Buy 23 Mar 2021
Value US$6,000,000.00 | Price 20.00 | Shares 300,000
Buy 23 Mar 2021
Value US$6,000,000.00 | Price 20.00 | Shares 300,000
Buy 23 Mar 2021
Value US$9,000,000.00 | Price 20.00 | Shares 450,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2025-09-12 2025-09-10 S Sale

CFO and CBO

Officer
73,489 +9.0%
162.14
US$2,463,912
73,489 +9.0% 162.14 US$2,463,912
2025-09-12 2025-09-10 S Sale

CFO and CBO

Officer
95,618 +22.9%
436.62
US$4,779,555
95,618 +22.9% 436.62 US$4,779,555
2025-09-10 2025-09-10 PrS Proposed sale

Officer

Officer
13,001
16.69
US$253,704
13,001 16.69 US$253,704
2021-03-25 2021-03-23 B Purchase Large shareholder
450,000 +1.2%
20.00
US$9,000,000
450,000 +1.2% 20.00 US$9,000,000
2021-03-25 2021-03-23 B Purchase Non-Executive Director
19,620 +inf%
20.00
US$392,400
19,620 +inf% 20.00 US$392,400
2021-03-25 2021-03-23 B Purchase Non-Executive Director
48,390 +inf%
20.00
US$967,800
48,390 +inf% 20.00 US$967,800
2021-03-25 2021-03-23 B Purchase Non-Executive Director
116,880 +24.3%
20.00
US$2,337,600
116,880 +24.3% 20.00 US$2,337,600
2021-03-25 2021-03-23 B Purchase Non-Executive Director
10,470 +1.9%
20.00
US$209,400
10,470 +1.9% 20.00 US$209,400
2021-03-25 2021-03-23 B Purchase Non-Executive Director
104,640 +1.9%
20.00
US$2,092,800
104,640 +1.9% 20.00 US$2,092,800
2021-03-25 2021-03-23 B Purchase

CEO and Chairman

Executive Director Large shareholder
450,000 +1.2%
20.00
US$9,000,000
450,000 +1.2% 20.00 US$9,000,000
2021-03-25 2021-03-23 B Purchase Non-Executive Director
300,000 +2.5%
20.00
US$6,000,000
300,000 +2.5% 20.00 US$6,000,000
2021-03-25 2021-03-23 B Purchase Large shareholder
300,000 +2.5%
20.00
US$6,000,000
300,000 +2.5% 20.00 US$6,000,000
2021-03-25 2021-03-23 B Purchase Non-Executive Director
450,000 +5.6%
20.00
US$9,000,000
450,000 +5.6% 20.00 US$9,000,000